JPRN-UMIN000025106Completed未知
Study of retinal venous pressure measured by Contact Lens Dynamometer - Study of retinal venous pressure measured by Contact Lens Dynamometer
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Osaka Medical College
- Enrollment
- 26
Study Overview
Brief Summary
Comparison of the BRVOs and CRVOs showed that VA was significantly improved by a single injection in BRVOs (P < 0.0001; P = 0.1087 for CRVOs), but CRT and RVP were significantly decreased without significant difference in IOP after the treatment in both groups (P < 0.0001).
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients who is difficult to be measured retinal venous pressure.
Investigators
Similar Trials
Completed
Phase 4
Visual functions in patients with diabetic macular edema following aflibercept therapy.JPRN-jRCTs031180161Okamoto Fumiki20
Completed
Not Applicable
Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein OcclusionsRetinal Vein OcclusionNCT05345808Al-Azhar University46
Completed
Phase 2
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular EdemaDiabetic Macular EdemaNCT02712008Regeneron Pharmaceuticals302
Completed
Phase 4
Comparative Study Between IVI of Ranibizumab with and Without Prior ACP in Patients with DME Using OCT-ADiabetic Macular EdemaNCT05861466Ain Shams University102
Completed
Phase 2
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionPrimary Open Angle GlaucomaOcular HypertensionNCT01379144Pfizer's Upjohn has merged with Mylan to form Viatris Inc.282